Cassava Sciences, Inc. (SAVA)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 12.75 |
| Open | 13.00 |
| Bid | 14.89 x 200 |
| Ask | 14.95 x 700 |
| Day's Range | 12.86 - 14.94 |
| 52 Week Range | 8.79 - 32.10 |
| Volume | |
| Avg. Volume | 2,074,254 |
| Market Cap | 715.805M |
| Beta (5Y Monthly) | -0.57 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec 13, 2012 |
| 1y Target Est | N/A |
- Zacks
Biotech Stock Roundup: LXRX Up on Regulatory Update, SAVA, LXEO Down on Updates
Cassava Sciences, Inc. (SAVA) and Lexeo Therapeutics (LXEO) are in the spotlight following updates.
- Yahoo Finance Video
Cassava forms committee after US probe, researcher fraud
Cassava Sciences (SAVA) is reportedly forming a committee to investigate two senior employees. This comes after a US probe into fraud and a Cassava researcher was indicted by a jury over alleged fabrication of Alzheimer's drug trial results. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.
- Barrons.com
Cassava Sciences Shares Plunge on Indictment Against Former Advisor
A federal indictment accuses a Cassava Sciences advisor of faking data to secure NIH grants. The company also faces shareholder suits.
© 2024 Yahoo. All rights reserved.